Integral Diagnostics Ltd. (AU:IDX) has released an update.
Integral Diagnostics Ltd. has reported a change in director Ian Kadish’s interests, with a lapse of 184,616 Performance Rights related to the company’s FY21 Long-Term Incentive (LTI) Plan, leaving him with 647,932 remaining Rights. No monetary transactions were involved in the change, which occurred on August 27, 2024. Kadish continues to hold 559,441 fully paid ordinary shares.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.
